Recombinant Mouse CDKN1B Protein，His

CDKN1B, also known as p27Kip1, is a crucial cell cycle regulator that functions as an inhibitor of cyclin-dependent kinases (CDKs). Its primary role is to maintain the balance between cell proliferation and differentiation, making it a key player in tumor suppression. Abnormal expression or mutation of CDKN1B has been linked to various cancers, including breast, prostate, and colon cancer, highlighting its significance in oncogenesis. The study of recombinant CDKN1B protein has gained momentum as it can serve as a valuable tool for understanding its molecular mechanisms and interactions with other cell cycle proteins. By producing this protein in a recombinant form, researchers can establish in vitro assays to unravel the complexities of its regulatory functions and identify potential therapeutic targets. Furthermore, recombinant CDKN1B can be utilized in drug screening assays to discover new anticancer compounds that aim to restore its normal function or enhance its activity. Recent advances in recombinant DNA technology have facilitated the production of CDKN1B at scale, allowing for extensive functional studies and the exploration of its roles in cellular signaling pathways, apoptosis, and proliferation. Such research endeavors not only enhance our understanding of cancer biology but also pave the way for innovative treatment strategies that could combat tumor growth by modulating the activity of this pivotal cell cycle regulator.